Analysis of NanoMosaic Closes a $40.75M Series A Round - aVenture Research
citybiz
NanoMosaic Closes a $40.75M Series A Round
NanoMosaic Inc., a Tiger Gene founded company that has established itself as the pioneer and leader in nanoneedle detection for proteomics and multi-omics applications, announced today that it has closed an oversubscribed $40,750,000 Series A round of financing led by RA Capital Management, joined by Insight Partners, Pura Vida Investments, Time BioVentures and Tiger Gene. Aiming to break the bottleneck in protein biomarker interrogation, NanoMosaic has developed a suite of analyte interrogation
An analysis reads this article and its sources, then explains what happened, who is involved, and what it means, quoting a source for each claim. Once written, every reader sees it here.
Analysis requires a paid plan or prepaid credits and uses your company research allowance.